- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04049292
Better and Safer Return to Sport (BEAST)
Better and Safer Return to Sport After Anterior Cruciate Ligament Reconstruction
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Fewer than half of athletes with ACLR return to competitive sports, and, for those who return, 1 in 5 sustain reinjury. Insufficient functional recovery and poor psychological readiness to RTS are thought to contribute to these low RTS rates and high reinjury rates. Previous research has shown that return to sport (RTS) should be delayed until the athlete passes the criteria of a clinical decision-making tool for RTS. However, to successfully improve RTS and reinjury outcomes, it is imperative that a decision-making tool (1) guides RTS decisions at a specific point in time, and (2) directs the planning and execution of treatments that eventually enable the athlete to safely RTS.
Nonprofessional athletes are often discharged from rehabilitation prior to RTS, and most are treated by rehabilitation clinicians who do not have access to the sophisticated and expensive test equipment used in previous research on functional readiness for RTS. The RTS and rehabilitation tool is therefore designed in collaboration with athletes, coaches and primary care physical therapists as a low-cost intervention that is feasible to implement on a broad scale.
The athletes who follow the RTS and rehabilitation tool will be recruited from Oslo, Norway, while the control group that receives usual care will be recruited from the Swedish Knee Ligament register (SPARX study Dnr 2019-04546).
Predefined adjustment factors for the comparative analyses are: age, sex, specific preinjury sport, family history of ACL injury, time from injury to surgery, meniscal and cartilage injury at ACLR, meniscal repair, and ACL graft type. The analysis of reinjury will be adjusted for sports exposure.
Objectives
- To compare 1 and 2-year sports participation, psychological readiness to RTS, knee function and reinjury outcomes between athletes with ACLR who follow a treatment algorithm with a RTS and rehabilitation tool and those who follow usual care
- To assess adherence and barriers to adherence in athletes with ACLR who follow a treatment algorithm with a RTS and rehabilitation tool
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Oslo, Norway, 0806
- Recruiting
- Norsk Idrettsmedisinsk Institutt
-
Oslo, Norway
- Recruiting
- Idrettens Helsesenter
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- primary anterior cruciate ligament reconstruction 6 months ago (+- 2 weeks)
- age 15-40 years at the time of anterior cruciate ligament injury
- preinjury participation in level I pivoting sport at least 2 times per week
- expressed goal to return to level I sport
Exclusion Criteria:
- grade 3 injury to the medial collateral ligament, lateral collateral ligament, or posterior cruciate ligament
- contralateral ACL tear
- inability to understand the native language in the country of recruitment
- other serious injury or illness that impairs function
- has access to specialist sports medicine care (e.g., health support from national team) not accessible to all athletes
- derives primary income from sports participation
- member of sports health team present at the majority of the team's training sessions
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: RTS and rehabilitation tool
Six months after ACLR, athletes will commence a standardized RTS assessment.
The athlete will follow a standardized, sport-specific progression protocol designed to increase athletic confidence and trust in the knee during sports.
Readiness to return to full, unrestricted practice will be determined based on 7 time-based, load-based, clinical and functional criteria.
If the athlete fails any of the criteria, he or she will continue to participate in restricted practice.
Depending on which of the specific criteria the athlete fails, a targeted treatment plan will be developed.
Standardized protocols for effusion management, knee control and strength training will be triggered if the athlete fails the criteria for knee joint effusion, hopping and muscle strength, respectively.
The RTS assessment and development of the targeted treatment plan will be repeated every 2 months until the athlete is cleared to RTS, up to a maximum of 12 months after ACLR.
|
The RTS assessment includes a Lachman test, modified stroke test, side hop test, triple hop test, and quadriceps muscle power test.
The sport-specific progression plans have 6 participation levels in practice and 6 participation levels in match play.
A minimum of 2 weeks and 4 training sessions without pain or effusion must be completed before the athlete progresses to the next level.
Criteria for full, unrestricted participation in practice: (1)at least 9 months from ACLR, (2)modified stroke test grade 0, (3)completed previous levels in the sport-specific progression plan, (4)negative Lachman test, (5)side hop test limb symmetry at least 90%, (6)triple hop test limb symmetry at least 90%, (7)quadriceps power symmetry at least 90%.
The strength training and knee control exercise protocols each have 3-4 different exercises of 3-4 sets that are performed 3 days per week.
|
|
Active Comparator: Usual care
Athletes will receive usual care as determined by their treating health care professional
|
Usual care is determined by the treating health care professional
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Return to sport
Time Frame: 2 years after ACLR
|
Participation in preinjury sport (yes/no)
|
2 years after ACLR
|
|
Reinjury
Time Frame: 2 years after ACLR
|
Injury to the ACL, medial or lateral meniscus in the ipsi- and contralateral knee (yes/no)
|
2 years after ACLR
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
International knee documentation committee subjective knee form
Time Frame: 2 years after ACLR
|
Patient-reported measure of knee symptoms, function and activity level, scored 0-100
|
2 years after ACLR
|
|
Anterior cruciate ligament return to sport after injury
Time Frame: 2 years after ACLR
|
Patient-reported measure of emotions, confidence in performance, and risk appraisal in relation to RTS, scored 0-100
|
2 years after ACLR
|
|
Adherence/fidelity to the intervention
Time Frame: Monthly self-report 7-14 months after ACLR
|
Project-specific questionnaire
|
Monthly self-report 7-14 months after ACLR
|
|
Barriers and motivating factors for adherence to the intervention
Time Frame: 14 months after ACLR
|
Self-reported on a project-specific questionnaire
|
14 months after ACLR
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sports participation
Time Frame: 2 years after ACLR
|
Self-reported participation in all sports/physical activity
|
2 years after ACLR
|
|
OSTRC overuse injury questionnaire
Time Frame: 2 years after ACLR
|
Oslo Sport Trauma Research Center overuse injury questionnaire
|
2 years after ACLR
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018/1886
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anterior Cruciate Ligament Injuries
-
Alexander Rofner-MorettiRecruitingAnterior Cruciate Ligament Rupture | Anterior Cruciate Ligament Reconstruction | Anterior Cruciate Ligament InjuryAustria
-
Haute Ecole ARC SanteCompletedAnterior Cruciate Ligament Injury | Anterior Cruciate Ligament Reconstruction RehabilitationSwitzerland
-
Medical University of GrazCompletedAnterior Cruciate Ligament Rupture | Anterior Cruciate Ligament Injury | Knee Instability | Anterior Cruciate Ligament Graft FailureAustria
-
Universidad de GranadaRecruitingAnterior Cruciate Ligament Injury | Anterior Cruciate Ligament (ACL) ReconstructionSpain
-
University of BathVersus ArthritisRecruitingPost-traumatic Osteoarthritis | Anterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament Tear | Anterior Cruciate Ligament ReconstructionUnited Kingdom
-
Ankara City Hospital BilkentRecruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearTurkey
-
Sanford HealthActive, not recruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearUnited States
-
University of Colorado, DenverChildren's Hospital ColoradoActive, not recruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearUnited States
-
eMKa MED Medical CenterWroclaw Medical UniversityRecruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament Tear | Knee Injuries | Knee Ligament InjuryPoland
-
University of CalgaryWorkers' Compensation Board, AlbertaCompletedAnterior Cruciate Ligament Rupture | Anterior Cruciate Ligament Injury | Chronic Instability of Knee | Deficiency of Anterior Cruciate LigamentCanada
Clinical Trials on Better and safer return to sport (BEAST)
-
Aalborg UniversityRecruitingOsgood-Schlatter DiseaseDenmark
-
University Hospital, CaenCompletedMuscle Weakness | Knee Injuries | ACL InjuryFrance
-
Aalborg UniversityCompletedOsgood Schlatter DiseaseDenmark
-
Haraldsplass Deaconess HospitalHaukeland University HospitalCompletedDevelopment of a Test Battery for Measurement of Knee Function in Patients With Patellar InstabilityPatellofemoral Joint Dislocation | Joint Instability | PatellaNorway
-
University of Texas at AustinNot yet recruitingHemorrhage | Bleeding | Trauma | Intracranial HemorrhagesUnited States
-
National Institute on Drug Abuse (NIDA)New York State Psychiatric InstituteCompletedSubstance-Related Disorders | Cocaine-Related DisordersUnited States
-
Horopito LimitedAtlantia Food Clinical TrialsCompleted
-
University Hospital, Strasbourg, FranceRecruitingHealth Related Quality of Life | Veno-arterial Extra-Corporeal Membrane OxygenationFrance
-
University of NimesNot yet recruitingMotivation | Mental Health Issue | Learning Problem | Student Burnout | Young Adults/ Students | University-based InterventionFrance
-
National University of SingaporeCompletedChild DevelopmentSingapore